Foa R - Search Results

1

IL2 treatment for cancer: from biology to gene therapy.

Foa R, Guarini A, Gansbacher B. Foa R, et al. Br J Cancer. 1992 Dec;66(6):992-8. doi: 10.1038/bjc.1992.400. Br J Cancer. 1992. PMID: 1457368 Free PMC article. Review.

2

Cytokine gene therapy in oncology.

Foa R, Cignetti A, Riera L, Gillio Tos A, Guarini A. Foa R, et al. Folia Biol (Praha). 1994;40(1-2):37-48. Folia Biol (Praha). 1994. PMID: 7958063 Review.

3

Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression.

Cignetti A, Guarini A, Carbone A, Forni M, Cronin K, Forni G, Gansbacher B, Foa R. Cignetti A, et al. Among authors: foa r. J Natl Cancer Inst. 1994 May 18;86(10):785-91. doi: 10.1093/jnci/86.10.785. J Natl Cancer Inst. 1994. PMID: 8169977

4

Cytokine gene therapy: a new strategy for the management of cancer patients.

Foa R, Guarini A, Cignetti A, Cronin K, Rosenthal F, Gansbacher B. Foa R, et al. Nat Immun. 1994 Mar-Jun;13(2-3):65-75. Nat Immun. 1994. PMID: 8173237 Review.

5

Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules.

Guarini A, Riera L, Cignetti A, Montacchini L, Massaia M, Foa R. Guarini A, et al. Among authors: foa r. Blood. 1997 Jan 1;89(1):212-8. Blood. 1997. PMID: 8978294 Free article.

6

Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder.

Milella M, Jacobelli J, Cavallo F, Guarini A, Velotti F, Frati L, Foà R, Forni G, Santoni A. Milella M, et al. Among authors: foa r. Br J Cancer. 1999 Feb;79(5-6):770-9. doi: 10.1038/sj.bjc.6690124. Br J Cancer. 1999. PMID: 10070868 Free PMC article.

7

Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.

Cignetti A, Guarini A, Gillio Tos A, Reato G, Foa R. Cignetti A, et al. Among authors: foa r. Cancer Gene Ther. 2000 Feb;7(2):167-76. doi: 10.1038/sj.cgt.7700107. Cancer Gene Ther. 2000. PMID: 10770624

8

Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.

Foa R, Guarini A, Gillio Tos A, Cardona S, Fierro MT, Meloni G, Tosti S, Mandelli F, Gavosto F. Foa R, et al. Cancer Res. 1991 Feb 1;51(3):964-8. Cancer Res. 1991. PMID: 1988139

9

Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings.

Foa R, Meloni G, Tosti S, Novarino A, Fenu S, Guarini A, Cardona S, Gillio Tos A, Gavosto F, Mandelli F. Foa R, et al. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:98-102. Bone Marrow Transplant. 1990. PMID: 2202476 Clinical Trial. No abstract available.

10

Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin.

Foa R, Caretto P, Fierro MT, Bonferroni M, Cardona S, Guarini A, Lista P, Pegoraro L, Mandelli F, Forni G, et al. Foa R, et al. Br J Haematol. 1990 May;75(1):34-40. doi: 10.1111/j.1365-2141.1990.tb02613.x. Br J Haematol. 1990. PMID: 2375921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

938 results

Search Page

Filters